Daniel Tibbits

NPI: 1922356658
Total Payments
$746.50
2024 Payments
$251.30
Companies
11
Transactions
40
Medicare Patients
449
Medicare Billing
$55,013

Payment Breakdown by Category

Food & Beverage$746.50 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $746.50 40 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $301.02 16 $0 (2024)
Otsuka America Pharmaceutical, Inc. $126.54 7 $0 (2024)
Lilly USA, LLC $85.06 5 $0 (2021)
Takeda Pharmaceuticals U.S.A., Inc. $65.97 3 $0 (2024)
AstraZeneca Pharmaceuticals LP $40.25 2 $0 (2024)
Dexcom, Inc. $39.95 2 $0 (2023)
Tactile Systems Technology Inc $25.33 1 $0 (2024)
Novo Nordisk Inc $19.55 1 $0 (2024)
Axsome Therapeutics, Inc. $15.21 1 $0 (2023)
Alkermes, Inc. $14.12 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $251.30 12 ABBVIE INC. ($88.67)
2023 $109.86 6 Otsuka America Pharmaceutical, Inc. ($33.25)
2022 $211.19 12 ABBVIE INC. ($135.95)
2021 $174.15 10 Lilly USA, LLC ($85.06)

All Payment Transactions

40 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/06/2024 Tactile Systems Technology Inc Flexitouch Plus (Device), Entre Plus Food and Beverage In-kind items and services $25.33 General
Category: PNEUMATIC COMPRESSOR
12/06/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $15.40 General
Category: PSYCHIATRY
11/22/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.84 General
Category: NEUROSCIENCE
10/04/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $19.50 General
Category: PSYCHIATRY
09/13/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $30.67 General
Category: NEUROSCIENCE
05/24/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $20.00 General
Category: Respiratory
04/26/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.00 General
Category: NEUROSCIENCE
04/19/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $26.00 General
Category: NEUROSCIENCE
04/12/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $16.60 General
Category: PSYCHIATRY
02/02/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $20.25 General
Category: Respiratory
01/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.16 General
Category: NEUROSCIENCE
01/12/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $19.55 General
Category: Diabetes
06/30/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $14.12 General
Category: CNS
06/23/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $15.75 General
Category: PSYCHIATRY
06/09/2023 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $20.00 General
Category: Endocrinology
04/08/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $27.28 General
Category: NEUROSCIENCE
03/04/2023 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $17.50 General
Category: PSYCHIATRY
01/13/2023 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $15.21 General
Category: Psychology/Psychiatric
12/06/2022 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $19.95 General
Category: Endocrinology
12/02/2022 Xeris Pharmaceuticals, Inc. KEVEYIS (Drug) Food and Beverage In-kind items and services $13.50 General
Category: Carbonic anhydrase inhibitor
10/14/2022 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $23.85 General
Category: PSYCHIATRY
08/25/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $5.14 General
Category: NEUROSCIENCE
07/13/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.52 General
Category: NEUROSCIENCE
07/01/2022 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $17.94 General
Category: PSYCHIATRY
06/16/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $5.63 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 33 52 $15,996 $3,507
2022 2 35 43 $9,410 $1,980
2021 2 27 37 $9,950 $2,047
2020 8 354 8,347 $205,067 $47,480
Total Patients
449
Total Services
8,479
Medicare Billing
$55,013
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 21 35 $12,168 $2,635 21.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 12 17 $3,827 $871.47 22.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 20 28 $8,960 $1,959 21.9%
96160 Administration and interpretation of patient-focused health risk assessment Office 2022 15 15 $450.00 $21.08 4.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 13 19 $6,080 $1,514 24.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 14 18 $3,870 $532.15 13.8%
J7320 Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg Office 2020 13 925 $31,450 $12,356 39.3%
J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg Office 2020 14 6,720 $36,019 $11,923 33.1%
64640 Destruction of peripheral nerve or branch Office 2020 21 89 $35,155 $9,067 25.8%
20611 Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance Office 2020 86 131 $38,610 $7,303 18.9%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 89 105 $22,668 $3,095 13.7%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 47 47 $22,795 $2,877 12.6%
64450 Injection of anesthetic agent and/or steroid into other peripheral nerve or branch Office 2020 21 22 $6,050 $560.98 9.3%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2020 63 308 $12,320 $298.19 2.4%

About Daniel Tibbits

Daniel Tibbits is a Nurse Practitioner healthcare provider based in Grants Pass, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2012. The National Provider Identifier (NPI) number assigned to this provider is 1922356658.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Tibbits has received a total of $746.50 in payments from pharmaceutical and medical device companies, with $251.30 received in 2024. These payments were reported across 40 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($746.50).

As a Medicare-enrolled provider, Tibbits has provided services to 449 Medicare beneficiaries, totaling 8,479 services with total Medicare billing of $55,013. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Grants Pass, OR
  • Active Since 08/28/2012
  • Last Updated 02/15/2021
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1922356658

Products in Payments

  • VRAYLAR (Drug) $252.21
  • ABILIFY MAINTENA (Drug) $75.89
  • TRINTELLIX (Drug) $65.97
  • REXULTI (Drug) $50.65
  • AIRSUPRA (Drug) $40.25
  • Dexcom G6 Transmitter (Medical Supply) $39.95
  • EMGALITY (Drug) $36.95
  • UBRELVY (Drug) $36.61
  • Flexitouch Plus (Device) $25.33
  • TRULICITY (Drug) $20.30
  • Ozempic (Drug) $19.55
  • JARDIANCE (Drug) $16.19
  • Auvelity (Drug) $15.21
  • ARISTADA (Drug) $14.12
  • KEVEYIS (Drug) $13.50
  • VIIBRYD (Drug) $12.20
  • REYVOW (Drug) $11.62

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Grants Pass